早期抗真菌治疗免疫受损患者,包括血液病和重症患者
Galina Klyasova1, Galina Solopova2, Jehad Abdalla3
1Department of Microbiology and Antimicrobial Therapy, National Medical Research Center for Hematology, 125167 Moscow, Russia.
Journal of fungi (Basel, Switzerland)
|January 27, 2026
概括
早期的实证抗真菌疗法对于疑似侵袭性真菌病 (IFD) 的免疫受损患者至关重要. 这一共识为及时启动治疗提供了基于证据的指导,改善了弱势群体的治疗结果.
科学领域:
- 传染性疾病 传染性疾病
- 菌类学 菌类学是指菌类学.
- 临床实践指南 临床实践指南
背景情况:
- 侵袭性真菌病 (IFD) 导致显著的发病率和死亡率,特别是在免疫功能低下的人群中.
- 及时诊断和治疗对于管理IFD至关重要.
研究的目的:
- 建立基于证据的共识,以早期的实证抗真菌治疗IFDs.
- 专注于高风险的血液学和重症患者.
主要方法:
- 多学科专家小组对文献的审查 (2013-2023年).
- 定义了针对 кандидоз,阿斯伯吉洛斯和粘菌的经验性抗真菌方法.
- 共识定义为≥75%的协议.
主要成果:
- 建议在怀疑IFD的高风险患者进行早期向的抗真菌治疗.
- 经验性治疗可以在诊断之前开始,考虑到当地的流行率和患者的风险.
- 密切监测和抗真菌类的潜在切换是必不可少的.
结论:
- 实施有针对性的,早期的实证抗真菌策略可以改善IFDs的脆弱患者的结果.
- 指导支持在重症监护和血液学设置中的及时干预.
相关概念视频
Patient-centered Care
3.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Drug Dosing: Obese Patients
242
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
242
Drug Dosing: Geriatric Patients
229
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
229
Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism
212
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
Pharmacodynamics in Geriatric Patients: Effects of Age
202
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
202


